Administration of protamine after coronary stent deployment (Q44064843)

29 November 2017

title

Administration of protamine after coronary stent deployment (English)

1 reference

29 November 2017

Briguori C

1

1 reference

29 November 2017

Di Mario C

2

1 reference

29 November 2017

De Gregorio J

3

1 reference

29 November 2017

Sheiban I

4

1 reference

29 November 2017

Vaghetti M

5

1 reference

29 November 2017

Colombo A

6

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 July 1999

1 reference

29 November 2017

published in

American Heart Journal

1 reference

29 November 2017

volume

138

1 reference

29 November 2017

issue

1 Pt 1

1 reference

29 November 2017

page(s)

64-68

1 reference

Increased coronary perforation in the new device era. Incidence, classification, management, and outcome

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970248-6

Perforations after percutaneous coronary interventions: clinical, angiographic, and therapeutic observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970248-6

Peripheral vascular complications of directional coronary atherectomy and stenting: predictors, management, and outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970248-6

Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970248-6

A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970248-6

Complement activation from protamine sulfate administration after coronary angiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970248-6

Protamine induces endothelium-dependent vasodilatation of the pulmonary artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970248-6

Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous T

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970248-6

Peripheral vascular complications in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT-I)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970248-6

Anticoagulation with heparin during cardiac catheterization and its reversal by protamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970248-6

Use of a direct antithrombin, hirulog, in place of heparin during coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970248-6

Coronary artery stenting in the elderly: short-term outcome and long-term angiographic and clinical follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970248-6

Subacute stent thrombosis in the era of intravascular ultrasound-guided coronary stenting without anticoagulation: frequency, predictors and clinical outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970248-6

In-laboratory removal of femoral sheath following protamine administration in patients having intracoronary stent implantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970248-6

10.1016/S0002-8703(99)70248-6

7 January 2021

Identifiers

DOI

1 reference

29 November 2017

1 reference